Moxifloxacin Hydrochloride Aurobindo

Moxifloxacin Hydrochloride, the active ingredient in Moxifloxacin Hydrochloride Aurobindo, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of serious bacterial infections, particularly in adult patients with community‑acquired pneumonia, acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and skin and skin‑structure infections.

GNH USA supplies Moxifloxacin Hydrochloride Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Moxifloxacin Hydrochloride is indicated for several bacterial infections affecting the respiratory tract and skin. - Community‑acquired bacterial pneumonia: reduces bacterial load and improves clinical outcomes in adult patients. - Acute bacterial sinusitis: eradicates causative pathogens and relieves sinus inflammation. - Acute bacterial exacerbation of chronic bronchitis: treats infection-driven worsening of chronic bronchitis symptoms. - Skin and skin structure infections: combats susceptible Gram‑positive and Gram‑negative bacteria in skin lesions.

Moxifloxacin Hydrochloride may cause adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial pain reported during therapy.

Serious or Rare Side Effects: - Tendon rupture: rare but severe injury to tendons, especially the Achilles. - QT interval prolongation: potential cardiac rhythm disturbance requiring monitoring. - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention.

Before prescribing Moxifloxacin Hydrochloride, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in patients with impaired clearance. - Review cardiac history: avoid use in individuals with known QT prolongation or arrhythmias. - Evaluate tendon health: discontinue if patient reports tendon pain or swelling. - Avoid concomitant use with drugs that prolong QT: monitor for additive cardiac effects. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Moxifloxacin Hydrochloride can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of the antibiotic. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: can raise cyclosporine concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation. - Theophylline: potential for elevated serum levels and side effects. - Corticosteroids: combined use may heighten risk of tendon rupture.